Cargando…

Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma

The International Neuroblastoma Pathology Classification (INPC) has a prognostic impact that distinguishes two categories of neuroblastoma: favorable histology (FH) and unfavorable histology (UH). We analyzed 92 cases of neuroblastoma with the INPC evaluation and genomic grouping to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakazawa, Atsuko, Haga, Chizuko, Ohira, Miki, Okita, Hajime, Kamijo, Takehiko, Nakagawara, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471784/ https://www.ncbi.nlm.nih.gov/pubmed/25827934 http://dx.doi.org/10.1111/cas.12665

Ejemplares similares

Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG) †
por: Ohira, Miki, et al.
Publicado: (2021)

Comparative epigenomics by machine learning approach for neuroblastoma
por: Sugino, Ryuichi P., et al.
Publicado: (2022)

EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications
por: Li, Zhenghao, et al.
Publicado: (2018)

Identification of the genetic and clinical characteristics of neuroblastomas using genome-wide analysis
por: Uryu, Kumiko, et al.
Publicado: (2017)

Apoptotic Cell Death in Neuroblastoma
por: Li, Yuanyuan, et al.
Publicado: (2013)

Experience with International Neuroblastoma Staging System and Pathology Classification
por: Ikeda, H, et al.
Publicado: (2002)

Radiomics analysis of contrast-enhanced computed tomography in predicting the International Neuroblastoma Pathology Classification in neuroblastoma
por: Wang, Haoru, et al.
Publicado: (2023)

Genomic analysis–integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway
por: Li, Yuanyuan, et al.
Publicado: (2017)

Oncogenic LMO3 Collaborates with HEN2 to Enhance Neuroblastoma Cell Growth through Transactivation of Mash1
por: Isogai, Eriko, et al.
Publicado: (2011)

How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
por: Akter, Jesmin, et al.
Publicado: (2021)

Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
por: Shinno, Yoshitaka, et al.
Publicado: (2022)

Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes
por: Watanabe, Noriko, et al.
Publicado: (2014)

Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas
por: Kaneko, Yoshiki, et al.
Publicado: (2015)

CFC1 is a cancer stemness-regulating factor in neuroblastoma
por: Chikaraishi, Koji, et al.
Publicado: (2017)

Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes
por: Su, Zhendong, et al.
Publicado: (2017)

Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells
por: Islam, S M Rafiqul, et al.
Publicado: (2015)

ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors
por: Parvin, Sultana, et al.
Publicado: (2023)

ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma
por: Hasan, Md. Kamrul, et al.
Publicado: (2013)

Neuronal leucine-rich repeat 1 negatively regulates anaplastic lymphoma kinase in neuroblastoma
por: Satoh, Shunpei, et al.
Publicado: (2016)

Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
por: Akter, Jesmin, et al.
Publicado: (2021)

Acceleration or Brakes: Which Is Rational for Cell Cycle-Targeting Neuroblastoma Therapy?
por: Ando, Kiyohiro, et al.
Publicado: (2021)

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
por: Ambros, P F, et al.
Publicado: (2009)

FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis
por: Ando, Kiyohiro, et al.
Publicado: (2021)

Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
por: Yagyu, Shigeki, et al.
Publicado: (2016)

The Role of MYCN in Symmetric vs. Asymmetric Cell Division of Human Neuroblastoma Cells
por: Izumi, Hideki, et al.
Publicado: (2020)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas
por: Ikematsu, S, et al.
Publicado: (2003)

The Evolution of Risk Classification for Neuroblastoma
por: Sokol, Elizabeth, et al.
Publicado: (2019)

Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma
por: Ho, Wan-Ling, et al.
Publicado: (2016)

The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN
por: Ando, Kiyohiro, et al.
Publicado: (2023)

Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma
por: NOZATO, MEGUMI, et al.
Publicado: (2012)

Correlation of CT signs with lymphatic metastasis and pathology of neuroblastoma in children
por: Zhang, Xinxian, et al.
Publicado: (2018)

DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN-Amplified Neuroblastoma IMR32 Cells
por: Ando, Kiyohiro, et al.
Publicado: (2023)

Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma
por: Chand, Damini, et al.
Publicado: (2013)

Neonatal acute megakaryoblastic leukemia mimicking congenital neuroblastoma
por: Kawasaki, Yukako, et al.
Publicado: (2015)

Congenital hypogonadotropic hypogonadism complicated by neuroblastoma
por: Ueta, Yukiko, et al.
Publicado: (2022)

NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers
por: Takatori, Atsushi, et al.
Publicado: (2021)

Serum Protein N-Glycosylation Signatures of Neuroblastoma
por: Qin, Wenjun, et al.
Publicado: (2021)

Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells
por: Ando, Kiyohiro, et al.
Publicado: (2019)

Gene signatures associated with genomic aberrations predict prognosis in neuroblastoma
por: He, Xiaoyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bp3m7s7mejvmanrvnbmhvhn5k1